ATHENA BIOMEDICAL CORP. LTD

Executive Summary

ATHENA BIOMEDICAL CORP. LTD is a newly incorporated dormant private limited company with minimal financial activity and no overdue statutory filings, presenting a low immediate risk. However, the absence of operational history and limited net assets warrant further inquiry into future business plans and governance arrangements, particularly given the overseas domicile of key individuals. Overall, current data does not indicate solvency or liquidity concerns but limits assessment of operational sustainability.

ATHENA BIOMEDICAL CORP. LTD - Analysis Report

Company Number: 15744115

Analysis Date: 2025-07-29 16:51 UTC

1. Risk Rating: LOW
   The company is classified as dormant with no trading activity, minimal financial complexity, and no overdue filings, indicating a low immediate risk profile.

2. Key Concerns:

• Dormant status means no operating revenue or trading history to assess operational viability or cash flow.
• Small net asset base (£10,000 share capital only) provides limited financial buffer if the company becomes active.
• Director and PSC based outside the UK (China) may present governance and oversight challenges, depending on the business model and jurisdictional risks.

3. Positive Indicators:

• Company is compliant with statutory filing requirements; accounts and confirmation statement are up-to-date and not overdue.
• No evidence of financial distress, insolvency proceedings, or regulatory sanctions.
• Clear ownership and control structure with PSC identified, meeting transparency standards.

4. Due Diligence Notes:

• Investigate plans for the company to commence trading and the source of initial funding or capital contributions.
• Validate the operational model, especially given the SIC codes indicating wholesale activities—clarify if these are planned or historical intentions.
• Assess the director’s experience and governance controls given the overseas domicile and potential challenges in oversight.
• Confirm no undisclosed liabilities or related party transactions that might affect future financial stability.